Other Information .
−Removed: During the quarter ended March 31, 2024 , no director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as each term is defined in Item 408 of Regulation S-K).
+Added: During the quarter ended June 30, 2024 , no director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as each term is defined in Item 408 of Regulation S-K).
The following exhibits are filed as part of, or incorporated by reference into, this report:
Description of Document
+Added: Share Purchase Agreement by and among Village Farms International, Inc., ROSE LifeScience Inc.
+Added: and shareholders of ROSE LifeScience, dated May 29, 2024 (effective as of April 1, 2024 )
+Added: Second Amended and Restated Credit Agreement by and between Village Farms Canada Limited Partnership and Village Farms, L.P.
+Added: and Bank of Montreal, dated May 24, 2024
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
11 unchanged sentences
Accounting Officer)
+Added: August 8, 2024
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.